HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD

Andere talen Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Aandelen

301126

CNE1000054V3

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 20-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8,88 ^CNY	-2,74%		-5,43%	-31,85%

05/06	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) begint met de inkoop van eigen aandelen ter waarde van CNY 15 miljoen, onder de machtiging goedgekeurd op 15 april 2024.	CI
22/04	Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd commences an Equity Buyback for CNY 15 million worth of its shares, under the authorization approved on April 15, 2024.	05/06
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	22/05
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Cash Dividend for 2023	15/05
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding	28/03
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24-10-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Board Elections	11-10-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed the share acquisition agreement to acquire 51% stake in Shanxi Simaile Pharmaceutical Chain Co., Ltd. from Yang Jinjiang, Liu Hongming for approximately CNY 330 million.	19-09-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	28-08-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire Yinchuan Meihetai Pharmaceutical Chain Co., Ltd. from Xie Huiyang and Xie Xiaolong for approximately CNY 250 million.	04-07-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 12, 2023	02-06-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Final Cash Dividend for 2022	15-05-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd cancelled the transaction announced on May 18, 2022	28-04-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 300 million in funding	28-04-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Proposes Final Cash Dividend for the Year 2022	24-04-23
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	21-04-23
Hunan Tongjian Pharmacy to Buy 86% Stake in Local Peer For 341 Million Yuan	03-01-23
Hunan Tongjian Pharma to Buy 86% of Local TCM Maker For 341 Million Yuan	23-12-22
Certain A Shares of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.	08-12-22
Hunan Dajiaweikang Pharma to Buy 85.7% Stake in Pharma Firm	16-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Aandelen

301126

CNE1000054V3

Andere talen

Filters